Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Clinical trial NCT01665677 · COMPLETED

Trial details

NCT number: NCT01665677
Sponsor: Mehdi Hamadani
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft vs Host Disease

Start date: 2014-01-20
Primary completion: 2021-07-09
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.